“…The spread of pathologic αS requires cellular uptake, the induction of aggregation of a physiologic population of αS, and the release of newly generated pathologic αS. Multiple cellular receptors have been described for αS fibril spread, including heparan sulfate proteoglycans, TLR2, neurexins, Na + /K + -ATPase subunit α3, Lag3, Aplp1, FcγRIIb, and the cellular prion protein [ 2 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 , 68 , 69 ]. The transmission of αS oligomers via an exosomal route has also been described, although there are conflicting reports regarding whether this exosomal pathway contributes to disease progression or is protective by reducing the intracellular pathologic αS burden when the capacity of the degradation machinery has been exceeded [ 70 , 71 , 72 , 73 ].…”